Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Ototoxic potential of erythromycin].

J E Demaldent, A Rolland, Y Mongrolle

    Annales D'Oto-Laryngologie Et De Chirurgie Cervico Faciale : Bulletin De La Societe D'Oto-Laryngologie Des Hopitaux De Paris
    |January 1, 1984
    PubMed
    Summary

    Erythromycin may cause early-onset hearing loss in patients with renal failure. This ototoxicity is reversible upon discontinuation of the antibiotic, unlike aminoglycosides.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Evaluating the adequacy of current dietary guidelines for seafood as a source of long-chain omega-3 fatty acids.

    Scientific reports·2026
    Same author

    Microendoscopic transventricular deep brain stimulation of the anterior nucleus of the thalamus as a safe treatment in intractable epilepsy: A feasibility study.

    Revue neurologique·2022
    Same author

    Prenatally Symptomatic Suprasellar Arachnoid Cyst: When to treat? A case-base update.

    Neuro-Chirurgie·2022
    Same author

    Management of patients suffering from hemorrhagic intracranial metastases: Propositions to help the neurosurgeon in emergency situations based on a literature review.

    Neuro-Chirurgie·2020
    Same author

    Surgery for recurrent medulloblastoma: A review.

    Neuro-Chirurgie·2019
    Same author

    TRANSPARENT TESTA 16 and 15 act through different mechanisms to control proanthocyanidin accumulation in Arabidopsis testa.

    Journal of experimental botany·2017

    Area of Science:

    • Pharmacology
    • Nephrology
    • Ototoxicology

    Background:

    • Erythromycin is a widely used macrolide antibiotic.
    • Renal failure can alter drug metabolism and excretion, increasing the risk of adverse effects.
    • Ototoxicity is a known, albeit uncommon, side effect of certain antibiotics.

    Observation:

    • A case study and literature review highlighted potential cochlear toxicity of erythromycin in patients with renal impairment.
    • Reported cases of erythromycin-induced hypoacusis manifested early in treatment.
    • Hearing loss resolved spontaneously after erythromycin cessation in all observed instances.

    Findings:

    • Erythromycin may induce ototoxicity, specifically cochlear damage, in patients with compromised renal function.
    • The ototoxic effects appear distinct from those of aminoglycoside antibiotics.
    • The precise mechanism underlying erythromycin-induced cochlear damage remains unelucidated.

    Implications:

    • Clinicians should exercise caution when prescribing erythromycin to individuals with renal failure.
    • Monitoring for early signs of hearing impairment is advisable in this patient population.
    • Further research is warranted to understand the mechanism of erythromycin ototoxicity.

    Related Experiment Videos